Grow Your Pharma Business Digitally
EU secures potential COVID-19 drugs from Roche, Germany's Merck – source
Could Amgen test Enbrel or other anti-TNF drugs in COVID-19?
Cipla launches generic version of remdesivir at Rs 4,000 per vial
Merck hits rare FDA setback for cancer drug Keytruda
AbbVie draws first blood in Botox trade secrets dispute
French biotech Osivax nabs funding boost for universal flu, covid vaccine work
Sanofi bags NK cells to boost effect of rival to J&J's Darzalex
Biogen tests FDA with controversial aducanumab filing
Trump claims vindication from Henry Ford HCQ study,scientists say it may skewed
Concert gets BTD for alopecia drug, setting up a late-stage showdown with Pfizer
Genentech, Amgen Settle Herceptin, Avastin Biosimilar Disputes
Mylan recalls daptomycin after particulates show up in vial
Business as usual on drug prices
Will the pharma industry keep collaborating after COVID-19? Novartis and Bristol
Can Biogen rebound in ALS? Maybe so, new antisense data suggest
A new study points to $6.5B in public support building the scientific foundation
Merck says it has agreed to supply potential COVID-19 drug Rebif to EU countries
Novavax, maker of a Covid-19 vaccine, is backed by Operation Warp Speed
Sandoz collaborates with Civica Rx to help reduce critical generic medicine shor...
Copyright © 2020 LePro PharmaCompass OPC Private Limited, All rights reserved.